Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Farp2 | Rat | 1,2-dimethylhydrazine | decreases expression | ISO | Farp2 (Mus musculus) | 6480464 | 1,2-Dimethylhydrazine results in decreased expression of FARP2 mRNA | CTD | PMID:22206623 | Farp2 | Rat | 1,2-dimethylhydrazine | multiple interactions | ISO | Farp2 (Mus musculus) | 6480464 | [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FARP2 mRNA | CTD | PMID:22206623 | Farp2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of FARP2 mRNA | CTD | PMID:32109520 | Farp2 | Rat | 2,3,7,8-Tetrachlorodibenzofuran | decreases expression | EXP | | 6480464 | 2,3,7,8-tetrachlorodibenzofuran results in decreased expression of FARP2 mRNA | CTD | PMID:32109520 | Farp2 | Rat | 4,4'-sulfonyldiphenol | decreases expression | ISO | Farp2 (Mus musculus) | 6480464 | bisphenol S results in decreased expression of FARP2 mRNA | CTD | PMID:39298647 | Farp2 | Rat | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of FARP2 mRNA | CTD | PMID:30047161 | Farp2 | Rat | all-trans-retinoic acid | decreases expression | ISO | FARP2 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of FARP2 mRNA | CTD | PMID:33167477 | Farp2 | Rat | amiodarone | increases expression | ISO | FARP2 (Homo sapiens) | 6480464 | Amiodarone results in increased expression of FARP2 mRNA | CTD | PMID:19774075 | Farp2 | Rat | amitrole | decreases expression | EXP | | 6480464 | Amitrole results in decreased expression of FARP2 mRNA | CTD | PMID:30047161|PMID:38685447 | Farp2 | Rat | arsenite(3-) | increases expression | ISO | Farp2 (Mus musculus) | 6480464 | arsenite results in increased expression of FARP2 protein | CTD | PMID:37955338 | Farp2 | Rat | benzo[a]pyrene | decreases expression | ISO | Farp2 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of FARP2 mRNA | CTD | PMID:20127859 | Farp2 | Rat | benzo[a]pyrene | affects methylation | ISO | FARP2 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of FARP2 5' UTR | CTD | PMID:27901495 | Farp2 | Rat | benzo[a]pyrene | increases methylation | ISO | FARP2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of FARP2 promoter | CTD | PMID:27901495 | Farp2 | Rat | benzo[a]pyrene | increases expression | ISO | FARP2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of FARP2 mRNA | CTD | PMID:22316170 | Farp2 | Rat | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of FARP2 mRNA | CTD | PMID:25181051 | Farp2 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of FARP2 mRNA | CTD | PMID:41034487 | Farp2 | Rat | bisphenol A | multiple interactions | ISO | FARP2 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of FARP2 gene | CTD | PMID:31601247 | Farp2 | Rat | bisphenol A | decreases expression | ISO | FARP2 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of FARP2 mRNA | CTD | PMID:33670352 | Farp2 | Rat | bisphenol A | increases expression | ISO | FARP2 (Homo sapiens) | 6480464 | bisphenol A results in increased expression of FARP2 protein | CTD | PMID:33376534 | Farp2 | Rat | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of FARP2 gene | CTD | PMID:28505145 | Farp2 | Rat | bisphenol A | affects methylation | ISO | Farp2 (Mus musculus) | 6480464 | bisphenol A affects the methylation of FARP2 promoter | CTD | PMID:27334623 | Farp2 | Rat | cadmium atom | multiple interactions | ISO | Farp2 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FARP2 more ... | CTD | PMID:37236586 | Farp2 | Rat | cadmium dichloride | multiple interactions | ISO | Farp2 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FARP2 more ... | CTD | PMID:37236586 | Farp2 | Rat | caffeine | affects phosphorylation | ISO | FARP2 (Homo sapiens) | 6480464 | Caffeine affects the phosphorylation of FARP2 protein | CTD | PMID:35688186 | Farp2 | Rat | carbon nanotube | decreases expression | ISO | Farp2 (Mus musculus) | 6480464 | Nanotubes, Carbon results in decreased expression of FARP2 mRNA | CTD | PMID:25554681 | Farp2 | Rat | CGP 52608 | multiple interactions | ISO | FARP2 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to FARP2 gene] | CTD | PMID:28238834 | Farp2 | Rat | chloroprene | increases expression | ISO | Farp2 (Mus musculus) | 6480464 | Chloroprene results in increased expression of FARP2 mRNA | CTD | PMID:23125180 | Farp2 | Rat | chlorpyrifos | decreases expression | ISO | Farp2 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of FARP2 mRNA | CTD | PMID:37019170 | Farp2 | Rat | diazinon | increases methylation | ISO | FARP2 (Homo sapiens) | 6480464 | Diazinon results in increased methylation of FARP2 gene | CTD | PMID:22964155 | Farp2 | Rat | doxorubicin | decreases expression | ISO | FARP2 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of FARP2 mRNA | CTD | PMID:29803840 | Farp2 | Rat | entinostat | increases expression | ISO | FARP2 (Homo sapiens) | 6480464 | entinostat results in increased expression of FARP2 mRNA | CTD | PMID:27188386 | Farp2 | Rat | ethanol | affects expression | ISO | Farp2 (Mus musculus) | 6480464 | Ethanol affects the expression of FARP2 mRNA | CTD | PMID:30319688 | Farp2 | Rat | folic acid | multiple interactions | ISO | Farp2 (Mus musculus) | 6480464 | [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FARP2 mRNA | CTD | PMID:22206623 | Farp2 | Rat | fulvestrant | multiple interactions | ISO | FARP2 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of FARP2 gene | CTD | PMID:31601247 | Farp2 | Rat | furan | decreases expression | EXP | | 6480464 | furan results in decreased expression of FARP2 mRNA | CTD | PMID:25539665 | Farp2 | Rat | methapyrilene | decreases expression | EXP | | 6480464 | Methapyrilene results in decreased expression of FARP2 mRNA | CTD | PMID:30467583 | Farp2 | Rat | methimazole | decreases expression | EXP | | 6480464 | Methimazole results in decreased expression of FARP2 mRNA | CTD | PMID:30047161 | Farp2 | Rat | okadaic acid | increases expression | ISO | FARP2 (Homo sapiens) | 6480464 | Okadaic Acid results in increased expression of FARP2 mRNA | CTD | PMID:38832940 | Farp2 | Rat | p-chloromercuribenzoic acid | increases expression | ISO | FARP2 (Homo sapiens) | 6480464 | p-Chloromercuribenzoic Acid results in increased expression of FARP2 mRNA | CTD | PMID:27188386 | Farp2 | Rat | paracetamol | affects expression | ISO | Farp2 (Mus musculus) | 6480464 | Acetaminophen affects the expression of FARP2 mRNA | CTD | PMID:17562736 | Farp2 | Rat | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of FARP2 mRNA | CTD | PMID:33387578 | Farp2 | Rat | paracetamol | increases expression | ISO | FARP2 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of FARP2 mRNA | CTD | PMID:22230336 | Farp2 | Rat | quercetin | increases expression | ISO | FARP2 (Homo sapiens) | 6480464 | Quercetin results in increased expression of FARP2 mRNA | CTD | PMID:21632981 | Farp2 | Rat | rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of FARP2 mRNA | CTD | PMID:28374803 | Farp2 | Rat | silicon dioxide | decreases expression | ISO | FARP2 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in decreased expression of FARP2 mRNA | CTD | PMID:25895662 | Farp2 | Rat | sodium arsenate | decreases expression | ISO | Farp2 (Mus musculus) | 6480464 | sodium arsenate results in decreased expression of FARP2 mRNA | CTD | PMID:30953684 | Farp2 | Rat | sulfadimethoxine | decreases expression | EXP | | 6480464 | Sulfadimethoxine results in decreased expression of FARP2 mRNA | CTD | PMID:30047161 | Farp2 | Rat | tetrachloromethane | increases expression | ISO | Farp2 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of FARP2 protein | CTD | PMID:17109383 | Farp2 | Rat | tetrachloromethane | decreases expression | ISO | Farp2 (Mus musculus) | 6480464 | Carbon Tetrachloride results in decreased expression of FARP2 mRNA | CTD | PMID:31919559 | Farp2 | Rat | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of FARP2 mRNA | CTD | PMID:23411599|PMID:34492290 | Farp2 | Rat | titanium dioxide | decreases methylation | ISO | Farp2 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of FARP2 promoter | CTD | PMID:35295148 | Farp2 | Rat | triphenyl phosphate | affects expression | ISO | FARP2 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of FARP2 mRNA | CTD | PMID:37042841 | Farp2 | Rat | urethane | increases expression | ISO | FARP2 (Homo sapiens) | 6480464 | Urethane results in increased expression of FARP2 mRNA | CTD | PMID:28818685 | Farp2 | Rat | valproic acid | increases expression | ISO | Farp2 (Mus musculus) | 6480464 | Valproic Acid analog results in increased expression of FARP2 mRNA; Valproic Acid results in increased more ... | CTD | PMID:21427059 | Farp2 | Rat | vinclozolin | increases expression | EXP | | 6480464 | vinclozolin results in increased expression of FARP2 mRNA | CTD | PMID:22570695 | Farp2 | Rat | vinclozolin | decreases methylation | EXP | | 6480464 | vinclozolin results in decreased methylation of FARP2 gene | CTD | PMID:31682807 | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






















